Komurian-Pradel; Florence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Komurian-Pradel; Florence.The latest application filed is for "retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses".

Company Profile

0.7.11

Komurian-Pradel; Florence - Poleymieux Au Mont D'Or FR
Komurian-Pradel; Florence - Saint Cyr Au Mont D'or FR
Komurian-Pradel; Florence - D'Or FR
Komurian-Pradel, Florence - Poleymieux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region Grant 8,088,910 - Paranhos-Baccala , et al. January 3, 2	2012-01-03
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes Grant 7,932,350 - Perron , et al. April 26, 2	2011-04-26
Retroviral Nucleic Material And Nucleotide Fragments, In Particular Associated With Multiple Sclerosis And/or Rheumatoid Arthritis, For Diagnostic, Prophylactic And Therapeutic Uses App 20100285448 - PARANHOS-BACCALA; Glaucia ; et al.	2010-11-11
Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region Grant 7,771,927 - Paranhos-Baccala , et al. August 10, 2	2010-08-10
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes Grant 7,674,888 - Perron , et al. March 9, 2	2010-03-09
LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus Grant 7,381,817 - Paranhos-Baccala , et al. June 3, 2	2008-06-03
Viral Material And Nucleotide Fragments Associated With Multiple Sclerosis, For Diagnostic, Prophylactic And Therapeutic Purposes App 20070117189 - PERRON; Herve ; et al.	2007-05-24
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes App 20070031452 - Perron; Herve ; et al.	2007-02-08
Method for culturing hcv virus in vitro App 20050221464 - Andre, Patrice ; et al.	2005-10-06
Method for in vitro culture of viruses of the togaviridae and flaviviridae families and uses App 20040229336 - Andre, Patrice ; et al.	2004-11-18
The LTR region of MSRV-1 and the proteins it encodes and probes and methods for detecting MSRV-1 retrovirus App 20040043381 - Paranhos-Baccala, Glaucia ; et al.	2004-03-04
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes App 20030198647 - Perron, Herve ; et al.	2003-10-23
Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose App 20030186391 - Perron, Herve ; et al.	2003-10-02
Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof App 20030129202 - Trepo, Christian ; et al.	2003-07-10
Complex of lipo-viro-particles, method of preparation and applications Grant 6,548,295 - Andre , et al. April 15, 2	2003-04-15
Isolated Nucleotide Sequences Associated With Multiple Sclerosis Or Rheumatoid Arthritis And A Process Of Detecting App 20030039664 - PERRON, HERVE ; et al.	2003-02-27
Complex Of Lipo-Viro-Particles, Method Of Preparation And Applications App 20020058044 - Andre, Patrice ; et al.	2002-05-16
Isolated nucleotide sequences associated with Multiple sclerosis Grant 6,001,987 - Perron , et al. December 14, 1	1999-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.